Effects of Histone Modification in Major Depressive Disorder

Curr Neuropharmacol. 2022;20(7):1261-1277. doi: 10.2174/1570159X19666210922150043.

Abstract

Major depressive disorder (MDD) is a disease associated with many factors; specifically, environmental, genetic, psychological, and biological factors play critical roles. Recent studies have demonstrated that histone modification may occur in the human brain in response to severely stressful events, resulting in transcriptional changes and the development of MDD. In this review, we discuss five different histone modifications, histone methylation, histone acetylation, histone phosphorylation, histone crotonylation and histone β-hydroxybutyrylation, and their relationships with MDD. The utility of histone deacetylase (HDAC) inhibitors (HDACis) for MDD treatment is also discussed. As a large number of MDD patients in China have been treated with traditional Chineses medicine (TCM), we also discuss some TCM therapies, such as Xiaoyaosan (XYS), and their effects on histone modification. In summary, targeting histone modification may be a new strategy for elucidating the mechanism of MDD and a new direction for MDD treatment.

Keywords: HDAC inhibitor; Major depressive disorder; histone acetylation; histone crotonylation; histone methylation; histone phosphorylation; histone β-hydroxybutyrylation.

Publication types

  • Review

MeSH terms

  • Acetylation
  • Depressive Disorder, Major* / drug therapy
  • Depressive Disorder, Major* / genetics
  • Histone Code
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors / therapeutic use
  • Histones / genetics
  • Humans
  • Protein Processing, Post-Translational

Substances

  • Histone Deacetylase Inhibitors
  • Histones